Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,601,810 papers from all fields of science
Search
Sign In
Create Free Account
PM060184
Known as:
DNA Minor Groove Binding Agent PM060184
A marine-derived, synthetically produced compound with potential antineoplastic activity. DNA minor groove-binding agent PM060184 covalently binds to…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Polyketides
Pyrones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
AACR 2018 : l’océan source de nouvelles molécules anticancer
D. Grazziotin-Soares
,
John-Paul Lotz
2018
Corpus ID: 81384693
Les composés d’origine marine constituent une source importante de substances naturelles. Cette source extrêmement diversifiée…
Expand
2018
2018
Abstract 3840: Plocabulin, a tubulin inhibitor, presents antitumor activity in patient-derived xenograft (PDX) models of gastrointestinal stromal tumor (GIST)
A. Wozniak
,
Yanni Wang
,
+7 authors
P. Schöffski
Experimental and Molecular Therapeutics
2018
Corpus ID: 81892821
Introduction: Advanced GIST is commonly treated with tyrosine kinase inhibitors (TKI) [e.g. imatinib (IMA)]. With time the vast…
Expand
2018
2018
Abstract 5876: Exploratory testing of PM060184 compound in high-grade serous ovarian carcinoma cell lines
V. Heredia-Soto
,
A. Redondo
,
+7 authors
M. Mendiola
Experimental and Molecular Therapeutics
2018
Corpus ID: 81717728
Purpose of the Study: Marine sponges have developed mechanisms to protect themselves from a hostile marine microenvironment. One…
Expand
2016
2016
Abstract 3066: Anti-angiogenic properties of PM060184
C. Galmarini
,
M. Guillén
,
Juan F Martínez-Leal
,
Marta Martínez-Díez
,
P. Avilés
2016
Corpus ID: 78371412
Vascular supply of tumors is one of the main targets for cancer therapy. Different studies have shown that most of the…
Expand
2015
2015
361 Phase I, open-label, dose-escalating clinical and pharmacokinetic study of the novel antimicrotubulin agent PM060184 administered over 10 minutes on days 1-3 and 15-17 every 28 days to patients…
M. Hidalgo
,
V. Boni
,
+15 authors
K. Papadopoulos
2015
Corpus ID: 78800902
2014
2014
Abstract 4654: Plasma, tissue and tumor pharmacokinetics of PM060184 in NSCL xenograft mouse model
Tiziana Pernice
,
A. Bishop
,
+6 authors
P. Avilés
2014
Corpus ID: 57894866
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Background: PM060184 is new marine derived tubulin-binding…
Expand
2014
2014
55 Low, frequent doses of PM060184 induce remarkable in vivo antitumor activity
P. Avilés
,
M. Guillén
,
+5 authors
M. Hidalgo
2014
Corpus ID: 71294109
2014
2014
Abstract 4534: In vivo antitumor activity of PM060184 in patient-derived xenografted tumors (avatar)
M. Hidalgo
,
M. Guillén
,
+5 authors
P. Avilés
2014
Corpus ID: 56814185
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Background: PM060184 is a synthetic marine-derived…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE